Stock exchanges & markets

Overview Watchlists

Samsung Biologics launches tender offer for PolyPeptide at CHF 44.31 per share

19. Jul 2026

(AWP Alliance News) - Samsung Biologics launched a tender offer to acquire PolyPeptide Group AG at CHF 44.31 per share. The offer was presented alongside PolyPeptide's preliminary first-half 2026 results, which pointed to faster growth and improved profitability.

PolyPeptide's board backed the approach, calling it a cash deal that provides immediate value while expanding the company's scale in peptide-based therapeutics.

https://www.publicnow.com/view/CA4ED1750AD075326D7320099D370C4AAEFB47F1…

Disclaimer: This news brief was created using generative artificial intelligence. PolyPeptide Group AG published the original content used to generate this news brief on July 20, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • ETF Compass

    Stock exchanges & markets

    ETFs are becoming increasingly popular. Our ETF Compass helps you maintain an overview. Filter by criteria such as asset class, region, rating, return or costs. 

    Try the ETF Compass now

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now